Login Sign in
Login Sign in

Join thousands of pet parents and get vet-approved guidance, product reviews, exclusive deals, and more!

Zenrelia™

(ilunocitinib tablets)

The NEW canine allergic itch treatment that works from day one, so your dog can get back to doing the things they love.1

There’s itch relief.
Then there’s Zenrelia.1

Is your dog licking, chewing, rubbing, or scratching more than usual? If so, they could be suffering from skin allergies that cause intense itchiness and inflammation. This discomfort can be either chronic or seasonal, and if left untreated, your pet is at risk of skin damage or infections.

Zenrelia is an innovative daily tablet that provides targeted itch relief from the very first dose so your dog can get back to normal faster – with noticeable improvements within just one day. Talk to your veterinarian to find out if prescription skin allergy support is right for your pet.

Please see Full Prescribing Information.

Zen is within your reach2

  • Works fast with visible improvements from day one
  • Breaks the itch-scratch cycle with targeted, continuous relief
  • Easy to give with or without food
  • Cost-effective – just one dose a day from the start

Frequently Asked Questions3

What is Zenrelia?

Zenrelia is a prescription medication used to control itching and skin inflammation associated with allergies in dogs at least 12 months of age.

Can Zenrelia be used long term?

Zenrelia can be used either short or long term to relieve itch flares, seasonal skin allergies, or chronic, ongoing itch and inflammation. There is no limit on duration of use.

What types of skin allergies does Zenrelia treat?

Zenrelia treats canine allergic dermatitis, which is an umbrella term encompassing many different pruritic (itch-causing) skin conditions. These include flea allergy dermatitis, food allergy dermatitis, contact dermatitis, and chronic atopic dermatitis. Ask your veterinarian if your dog could benefit from prescription allergic itch relief.

Is it safe to vaccinate dogs while they are on Zenrelia?

To avoid the risk of fatal vaccine-induced disease from modified live virus vaccines and inadequate immune response to vaccines, dogs should not take Zenrelia for a time period before and after vaccination. Dogs should be up to date on vaccinations prior to starting treatment with Zenrelia. Please discuss your dog’s vaccine schedule with your veterinarian and refer to the Important Safety Information below for further details.

Highly rated by vets and dog owners1

IMPORTANT SAFETY INFORMATION:

See package insert including the Boxed Warning. For full prescribing information, speak with your veterinarian, call 1-888-545-5973, or visit www.elancolabels.com/us/zenrelia

WARNING: VACCINE-INDUCED DISEASE AND INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of fatal vaccine-induced disease and inadequate immune response to vaccines. Dogs should not take Zenrelia for a time period before and after vaccination. Discuss your dog’s vaccine schedule with your veterinarian. Dogs should be up to date on vaccinations prior to starting Zenrelia. Do not use in dogs less than 12 months old or dogs with a serious infection. Dogs should be monitored for the development of infections because Zenrelia may increase the chances of developing an infection. Neoplastic conditions (benign and malignant) were observed during clinical studies. The most common side effects were vomiting, diarrhea, and tiredness. Zenrelia has not been tested in dogs used for breeding, pregnant, or lactating dogs, and has not been evaluated in combination with glucocorticoids, cyclosporine, or other immune-suppressive drugs.

Sources:
1 Zenrelia product website https://yourpetandyou.elanco.com/us/campaign/zenrelia Accessed online OCT 17, 2024.
2 Zenrelia product website https://my.elanco.com/us/campaign/zenrelia Accessed online OCT 17, 2024.
3 Zenrelia FAQ website https://my.elanco.com/us/zenrelia#first Accessed online OCT 17, 2024.
For full product information, including risks and/or side effects, visit https://assets.elanco.com/0cec44ed-3eaa-0009-2029-666567e7e4de/d6748957-10f4-4348-a1f5-84b4bea8c346/Zenrelia%20Dosing%20Card%20Final.pdf
Zenrelia™ is a trademark of Elanco, used under license. Trademarks are the property of their respective owners.

Learn more